Literature DB >> 32269358

Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.

Deepak Jakhar1, Ishmeet Kaur2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32269358     DOI： 10.1038/s41591-020-0853-0

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  27 in total

1.  DeepH-DTA: Deep Learning for Predicting Drug-Target Interactions: A Case Study of COVID-19 Drug Repurposing.

Authors:  Mohamed Abdel-Basset; Hossam Hawash; Mohamed Elhoseny; Ripon K Chakrabortty; Michael Ryan
Journal:  IEEE Access       Date:  2020-09-15       Impact factor: 3.367

2.  Protocol of Pakistan randomized and observational trial to evaluate coronavirus treatment among newly diagnosed patients with COVID-19: Azithromycin, Oseltamivir, and Hydroxychloquine.

Authors:  Shehnoor Azhar; Javed Akram; Muhammad Shahzad; Waqas Latif; Khalid Saeed Khan
Journal:  Pak J Med Sci       Date:  2022 May-Jun       Impact factor: 2.340

3.  Global Disparity and Solidarity in a Pandemic.

Authors:  Anita Ho; Iulia Dascalu
Journal:  Hastings Cent Rep       Date:  2020-05       Impact factor: 2.683

4.  Identification of Falsified Chloroquine Tablets in Africa at the Time of the COVID-19 Pandemic.

Authors:  Gesa Gnegel; Cathrin Hauk; Richard Neci; Georges Mutombo; Fidelis Nyaah; Dorothee Wistuba; Christine Häfele-Abah; Lutz Heide
Journal:  Am J Trop Med Hyg       Date:  2020-05-11       Impact factor: 2.345

5.  Editorial: Herd mentality, herds of migrants/people, and COVID-19 in India.

Authors:  Awadhesh Kumar Singh; Anoop Misra
Journal:  Diabetes Metab Syndr       Date:  2020-05-05

Review 6.  Novel therapeutic approaches for treatment of COVID-19.

Authors:  Nikoo Hossein-Khannazer; Bahare Shokoohian; Anastasia Shpichka; Hamid Asadzadeh Aghdaei; Peter Timashev; Massoud Vosough
Journal:  J Mol Med (Berl)       Date:  2020-06-03       Impact factor: 5.606

7.  Dermatological therapies with relevance to COVID-19.

Authors:  Mansak Shishak; Rashmi Sarkar
Journal:  Dermatol Ther       Date:  2020-07-05       Impact factor: 3.858

8.  Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.

Authors:  Farnoosh Seirafianpour; Sogand Sodagar; Arash Pour Mohammad; Parsa Panahi; Samaneh Mozafarpoor; Simin Almasi; Azadeh Goodarzi
Journal:  Dermatol Ther       Date:  2020-08-06       Impact factor: 3.858

9.  The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic.

Authors:  Monica Shah; Muskaan Sachdeva; Roni P Dodiuk-Gad
Journal:  Dermatol Ther       Date:  2020-06-05       Impact factor: 3.858

Review 10.  The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach.

Authors:  Sahar Najafi; Elham Rajaei; Rezvan Moallemian; Forough Nokhostin
Journal:  Clin Rheumatol       Date:  2020-09-03       Impact factor: 3.650
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.